gainsfueluk.com
No products in the cart.
Return To Shopgainsfueluk.com
No products in the cart.
Return To ShopCobix 200 mg is a pharmaceutical product manufactured by Cipla, a reputable name in the field of medicines. This drug is primarily based on the active ingredient Celecoxib, classified as a non-steroidal anti-inflammatory drug (NSAID). Cobix 200 mg is authorized for use in alleviating pain and inflammation associated with various conditions such as arthritis, menstrual pains, and other types of acute pain. Its mechanism of action involves inhibiting cyclooxygenase-2 (COX-2), which plays a critical role in the inflammation process. Cobix is designed to provide effective relief with a potentially reduced risk of stomach-related side effects than traditional NSAIDs due to its selective COX-2 inhibition.
The product is presented in 200 mg capsule form, making it convenient for both patients and athletes looking for anti-inflammatory relief. It is essential for users to adhere to the recommended dosage to maximize benefits while minimizing risks. Cobix holds a prominent position in sports pharmacology as athletes often encounter muscles and joint injuries, seeking effective management strategies.
Cobix 200 mg has gained attention in the field of sports pharmacology for its potential effects on endurance and overall athletic performance. Athletes may use Cobix to manage pain and inflammation, which can greatly enhance their training and competitive results. The following points highlight its implications on endurance:
While many athletes report favorable outcomes after using Cobix, it is essential to remember that individual results may vary based on factors like overall health, type of sport, and adherence to dosages. Always consult a healthcare professional before integrating such pharmaceuticals into a training regimen.
As with any medication, potential side effects may occur with the use of Cobix 200 mg. Common side effects can include gastrointestinal issues such as nausea, diarrhea, or stomach ulcers, and cardiovascular problems like hypertension or increased risk of heart attack in susceptible individuals. Therefore, it is crucial for users to monitor their health and consult with healthcare professionals regularly.
The maximum safe dosage of Cobix typically recommended for adults is 400 mg per day, divided into two doses. However, individual circumstances may require alternative dosing regimens. Never exceed 400 mg in a day without medical guidance. Athletes must remain vigilant, as misuse or overuse can lead to serious health complications or even disqualification in competitive sports as certain organizations may categorize it as a controlled substance.
Cobix 200 mg can be conveniently purchased through various online pharmacies and local drugstores. However, it is crucial to buy from reputable sources to ensure the legitimacy of the product. The official Cipla website and pharmacies associated with them are reliable places to acquire Cobix. Furthermore, you can check for authorized international healthcare suppliers who stock genuine products. When ordering online, always verify that the pharmacy requires a prescription and has a licensed pharmacist available for consultation.
When considering the use of Cobix 200 mg, following practical recommendations can optimize its benefits:
These recommendations can help athletes and individuals using Cobix 200 mg to enhance their experience while promoting their health and well-being.
| Active substance | Celecoxib |
|---|---|
| Water Retention | Minimal to none |
| Hepatotoxicity | Low (rare cases of liver toxicity) |
| Lab Test | Not typically required for monitoring, may monitor liver enzymes if necessary |
| Strength | 200mg |
| Also known as | Celebrex |
| Blood pressure | Can increase blood pressure in some individuals |
| Trade name | Celebrex |
| Storage conditions | Store at 20В°C to 25В°C (68В°F to 77В°F), protect from moisture |
| Chemical name | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide |
| Formula | C17H14F3N3O2S |
| Substance class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Main action | COX-2 inhibitor |
| Half-life | Approximately 11 hours |
| Dosage (medical) | Typically 100 mg to 200 mg daily in one or two divided doses |
| Dosage (sports) | Not applicable, as it is not used to enhance athletic performance |
| Effects | Reduces inflammation, pain, and fever |
| Side effects | Gastrointestinal upset, cardiovascular risk, renal impairment, risk of serious skin reactions |
| Use in sports | Not typically used in sports for performance enhancement |
| Manufacturer | Cipla Ltd. |
| Packing | 10 caps/blister |
€840.00
Reviews
There are no reviews yet.